061250 — Hwail Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Hwail Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37,691	89,198	75,348	71,844	72,255
Net Total Accounts Receivable
Net Total Receivables	33,784	32,366	33,159	28,511	30,624
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	106,395	148,833	138,068	136,629	133,789
Net Property, Plant And Equipment	34,371	30,633	31,559	32,927	65,584
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	169,676	194,147	185,597	186,001	215,610
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,362	12,071	7,941	11,026	11,713
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	12,816	12,489	10,024	11,548	12,194
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	156,860	181,658	175,573	174,454	203,415
Total Liabilities & Shareholders' Equity	169,676	194,147	185,597	186,001	215,610
Total Common Shares Outstanding